Mithu Maheswaranathan, MD @MithuRheum
113.9K 45 32
Rheumatologist at Duke University Creator of Rheum OnePagers ➡ RheumOnePagers.com Twitter: @MithuRheum ➡ https://twitter.com/MithuRheum
Contributor Ranks
Latest Searches
17 results
rheumatology guidelines treatment acr2021 diagnosis vasculitis anca arteritis arthritis differential granulomatosis lupus nephrology polyangiitis rheumatoid scleroderma sle systemic vaccine ana
Guidelines for Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip
Perioperative Management ... perioperative #guidelines #management ... #autoimmune #pharmacology
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management • Giant Cell Arteritis (GCA) •
Vasculitis Management ... for Treatment & Management ... #Vasculitis #Management ... ACR2021 #Guidelines #algorithm
Polyarteritis Nodosa (PAN) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines • Severe Disease → Remission
) - Vasculitis Management ... Algorithm - ACR ... Nodosa #Vasculitis #Management ... ACR2021 #Guidelines #algorithm
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021
ANCA Vasculitis Management ... Algorithm - ACR ... ANCA #Vasculitis #Management ... ACR2021 #Guidelines #algorithm
Antinuclear Antibodies (ANA) ANA or Anti-NucIear Antibody refers to antibodies against antigens in the nucleus → like
Positive ANA ≠ Autoimmune ... Disorders, Infection, Autoimmune ... Thyroid, Autoimmune
Giant Cell Arteritis (GCA) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines • Visual Symptoms/Loss or
) - Vasculitis Management ... Algorithm - ACR ... GCA #Vasculitis #Management ... ACR2021 #Guidelines #algorithm
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines • Active
ANCA Vasculitis Management ... Algorithm - ACR ... ANCA #Vasculitis #Management ... ACR2021 #Guidelines #algorithm
Rheumatoid Arthritis - ACR 2021 Guidelines - Low Disease Activity - Moderate to High Disease Activity
ACR2021 #Guidelines #management
Systemic Sclerosis (Scleroderma) Multi-system autoimmune disease characterized by vasculopathy and progressive fibrosis of skin and internal organs 3
Multi-system autoimmune
Lupus Nephritis Primer Class I - Minimal Mesangial Class II - Mesangial Proliferative Class Ill - Focal Proliferative Class IV
differential #diagnosis #management
empty